{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T05:44:01Z","timestamp":1792820641568,"version":"4.5.0"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100022247","name":"Precision Health Research, Singapore","doi-asserted-by":"publisher","award":["Health and Economic Impact of Next Generation Sequencing in Primary Glomerular Diseases in Singapore (PGD)"],"award-info":[{"award-number":["Health and Economic Impact of Next Generation Sequencing in Primary Glomerular Diseases in Singapore (PGD)"]}],"id":[{"id":"10.13039\/501100022247","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022247","name":"Precision Health Research, Singapore","doi-asserted-by":"publisher","award":["MOH-000588"],"award-info":[{"award-number":["MOH-000588"]}],"id":[{"id":"10.13039\/501100022247","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-92520-9","type":"journal-article","created":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T02:15:31Z","timestamp":1741140931000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Pathogenic variants in the Alport genes are prevalent in the Singapore multiethnic population with highest frequency in the Chinese"],"prefix":"10.1038","volume":"15","author":[{"given":"Tina Si Ting","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chee Teck","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Savige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvin Yu-Jin","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Li","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Lin","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weng Khong","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gek Cher","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"See Cheng","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther Hui Min","family":"Leow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedict Junrong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kar Hui","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaochun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,5]]},"reference":[{"key":"92520_CR1","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.kint.2017.12.018","volume":"93","author":"CE Kashtan","year":"2018","unstructured":"Kashtan, C. E. et al. Alport syndrome: A unified classification of genetic disorders of collagen IV alpha345: A position paper of the Alport syndrome classification working group. Kidney Int. 93, 1045\u20131051. https:\/\/doi.org\/10.1016\/j.kint.2017.12.018 (2018).","journal-title":"Kidney Int."},{"key":"92520_CR2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/ncpneph0671","volume":"4","author":"MC Gubler","year":"2008","unstructured":"Gubler, M. C. Inherited diseases of the glomerular basement membrane. Nat. Clin. Pract. Nephrol. 4, 24\u201337. https:\/\/doi.org\/10.1038\/ncpneph0671 (2008).","journal-title":"Nat. Clin. Pract. Nephrol."},{"key":"92520_CR3","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1038\/s41598-022-06525-9","volume":"12","author":"JT Gibson","year":"2022","unstructured":"Gibson, J. T. et al. Genotype\u2013phenotype correlations for COL4A3\u2013COL4A5 variants resulting in gly substitutions in Alport syndrome. Sci. Rep. 12, 2722. https:\/\/doi.org\/10.1038\/s41598-022-06525-9 (2022).","journal-title":"Sci. Rep."},{"key":"92520_CR4","doi-asserted-by":"publisher","first-page":"119857","DOI":"10.1016\/j.biomaterials.2020.119857","volume":"240","author":"J Yeo","year":"2020","unstructured":"Yeo, J. et al. Adverse effects of Alport syndrome-related Gly missense mutations on collagen type IV: Insights from molecular simulations and experiments. Biomaterials 240, 119857. https:\/\/doi.org\/10.1016\/j.biomaterials.2020.119857 (2020).","journal-title":"Biomaterials"},{"key":"92520_CR5","doi-asserted-by":"publisher","unstructured":"Adone, A. & Anjankar, A. Alport Syndrome Compr. Rev. Cureus 15, e47129. https:\/\/doi.org\/10.7759\/cureus.47129 (2023).","DOI":"10.7759\/cureus.47129"},{"key":"92520_CR6","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1053\/j.ajkd.2021.04.017","volume":"78","author":"J Savige","year":"2021","unstructured":"Savige, J. & Harraka, P. Pathogenic variants in the genes affected in Alport syndrome (COL4A3-COL4A5) and their association with other kidney conditions: A review. Am. J. Kidney Dis. 78, 857\u2013864. https:\/\/doi.org\/10.1053\/j.ajkd.2021.04.017 (2021).","journal-title":"Am. J. Kidney Dis."},{"key":"92520_CR7","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1186\/s12882-021-02567-9","volume":"22","author":"A Bhattacharyya","year":"2021","unstructured":"Bhattacharyya, A., Huang, Y., Khan, S. H., Drachenberg, C. B. & Malone, L. C. Tale of two nephropathies; co-occurring Alport syndrome and IgA nephropathy, a case report. BMC Nephrol. 22, 358. https:\/\/doi.org\/10.1186\/s12882-021-02567-9 (2021).","journal-title":"BMC Nephrol."},{"key":"92520_CR8","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ekir.2019.09.004","volume":"5","author":"A Gulati","year":"2020","unstructured":"Gulati, A. et al. Collagen IV gene mutations in adults with bilateral renal cysts and CKD. Kidney Int. Rep. 5, 103\u2013108. https:\/\/doi.org\/10.1016\/j.ekir.2019.09.004 (2020).","journal-title":"Kidney Int. Rep."},{"key":"92520_CR9","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1046\/j.1523-1755.2003.00234.x","volume":"64","author":"J Savige","year":"2003","unstructured":"Savige, J. et al. Thin basement membrane nephropathy. Kidney Int. 64, 1169\u20131178. https:\/\/doi.org\/10.1046\/j.1523-1755.2003.00234.x (2003).","journal-title":"Kidney Int."},{"key":"92520_CR10","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1159\/000435789","volume":"130","author":"C Deltas","year":"2015","unstructured":"Deltas, C., Savva, I., Voskarides, K., Papazachariou, L. & Pierides, A. Carriers of autosomal recessive Alport syndrome with thin basement membrane nephropathy presenting as focal segmental glomerulosclerosis in later life. Nephron 130, 271\u2013280. https:\/\/doi.org\/10.1159\/000435789 (2015).","journal-title":"Nephron"},{"key":"92520_CR11","doi-asserted-by":"publisher","first-page":"85","DOI":"10.5414\/cnp64085","volume":"64","author":"U Persson","year":"2005","unstructured":"Persson, U., Hertz, J. M., Wieslander, J. & Segelmark, M. Alport syndrome in Southern Sweden. Clin. Nephrol. 64, 85\u201390. https:\/\/doi.org\/10.5414\/cnp64085 (2005).","journal-title":"Clin. Nephrol."},{"key":"92520_CR12","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1111\/j.1651-2227.1996.tb13915.x","volume":"85","author":"H Pajari","year":"1996","unstructured":"Pajari, H., K\u00e4\u00e4ri\u00e4inen, H., Muhonen, T. & Koskimies, O. Alport\u2019s syndrome in 78 patients: Epidemiological and clinical study. Acta Paediatr. 85, 1300\u20131306. https:\/\/doi.org\/10.1111\/j.1651-2227.1996.tb13915.x (1996).","journal-title":"Acta Paediatr."},{"key":"92520_CR13","first-page":"1241","volume":"35","author":"SJ Hasstedt","year":"1983","unstructured":"Hasstedt, S. J. & Atkin, C. L. X-linked inheritance of Alport syndrome: Family P revisited. Am. J. Hum. Genet. 35, 1241\u20131251 (1983).","journal-title":"Am. J. Hum. Genet."},{"key":"92520_CR14","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1681\/ASN.2020071065","volume":"32","author":"J Gibson","year":"2021","unstructured":"Gibson, J. et al. Prevalence estimates of predicted pathogenic COL4A3-COL4A5 variants in a population sequencing database and their implications for Alport syndrome. J. Am. Soc. Nephrol. 32, 2273\u20132290. https:\/\/doi.org\/10.1681\/ASN.2020071065 (2021).","journal-title":"J. Am. Soc. Nephrol."},{"key":"92520_CR15","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1016\/j.ekir.2023.07.010","volume":"8","author":"KV Solanki","year":"2023","unstructured":"Solanki, K. V. et al. The phenotypic spectrum of COL4A3 heterozygotes. Kidney Int. Rep. 8, 2088\u20132099. https:\/\/doi.org\/10.1016\/j.ekir.2023.07.010 (2023).","journal-title":"Kidney Int. Rep."},{"key":"92520_CR16","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/s41591-020-0982-5","volume":"26","author":"JJ Grzymski","year":"2020","unstructured":"Grzymski, J. J. et al. Population genetic screening efficiently identifies carriers of autosomal dominant diseases. Nat. Med. 26, 1235\u20131239. https:\/\/doi.org\/10.1038\/s41591-020-0982-5 (2020).","journal-title":"Nat. Med."},{"key":"92520_CR17","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s41586-021-03855-y","volume":"597","author":"Q Wang","year":"2021","unstructured":"Wang, Q. et al. Rare variant contribution to human disease in 281,104 UK biobank exomes. Nature 597, 527\u2013532. https:\/\/doi.org\/10.1038\/s41586-021-03855-y (2021).","journal-title":"Nature"},{"key":"92520_CR18","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/s41586-019-1793-z","volume":"576","author":"KC GenomeAsia","year":"2019","unstructured":"GenomeAsia, K. C. The genomeasia 100K project enables genetic discoveries across Asia. Nature 576, 106\u2013111. https:\/\/doi.org\/10.1038\/s41586-019-1793-z (2019).","journal-title":"Nature"},{"key":"92520_CR19","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1126\/science.1177074","volume":"326","author":"HPAS Consortium","year":"2009","unstructured":"Consortium, H. P. A. S. et al. Mapping human genetic diversity in Asia. Science 326, 1541\u20131545. https:\/\/doi.org\/10.1126\/science.1177074 (2009).","journal-title":"Science"},{"key":"92520_CR20","doi-asserted-by":"publisher","first-page":"6694","DOI":"10.1038\/s41467-022-34116-9","volume":"13","author":"SH Chan","year":"2022","unstructured":"Chan, S. H. et al. Analysis of clinically relevant variants from ancestrally diverse Asian genomes. Nat. Commun. 13, 6694. https:\/\/doi.org\/10.1038\/s41467-022-34116-9 (2022).","journal-title":"Nat. Commun."},{"key":"92520_CR21","doi-asserted-by":"publisher","first-page":"e0178630","DOI":"10.1371\/journal.pone.0178630","volume":"12","author":"C Chiereghin","year":"2017","unstructured":"Chiereghin, C. et al. Alport syndrome cold cases: Missing mutations identified by exome sequencing and functional analysis. PLoS One 12, e0178630. https:\/\/doi.org\/10.1371\/journal.pone.0178630 (2017).","journal-title":"PLoS One"},{"key":"92520_CR22","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/cge.12247","volume":"86","author":"BD Webb","year":"2014","unstructured":"Webb, B. D. et al. A founder mutation in COL4A3 causes autosomal recessive Alport syndrome in the Ashkenazi Jewish population. Clin. Genet. 86, 155\u2013160. https:\/\/doi.org\/10.1111\/cge.12247 (2014).","journal-title":"Clin. Genet."},{"key":"92520_CR23","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1007\/s00467-021-05040-9","volume":"36","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y. et al. Genotype-phenotype correlations and nephroprotective effects of RAAS Inhibition in patients with autosomal recessive Alport syndrome. Pediatr. Nephrol. 36, 2719\u20132730. https:\/\/doi.org\/10.1007\/s00467-021-05040-9 (2021).","journal-title":"Pediatr. Nephrol."},{"key":"92520_CR24","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1002\/ajmg.a.35528","volume":"158a","author":"Y Zhang","year":"2012","unstructured":"Zhang, Y. et al. Genotype-phenotype correlations in 17 Chinese patients with autosomal recessive Alport syndrome. Am. J. Med. Genet. A. 158a, 2188\u20132193. https:\/\/doi.org\/10.1002\/ajmg.a.35528 (2012).","journal-title":"Am. J. Med. Genet. A"},{"key":"92520_CR25","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1681\/asn.2013080912","volume":"25","author":"V Morini\u00e8re","year":"2014","unstructured":"Morini\u00e8re, V. et al. Improving mutation screening in Familial hematuric nephropathies through next generation sequencing. J. Am. Soc. Nephrol. 25, 2740\u20132751. https:\/\/doi.org\/10.1681\/asn.2013080912 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"key":"92520_CR26","doi-asserted-by":"publisher","first-page":"4721","DOI":"10.12998\/wjcc.v9.i18.4721","volume":"9","author":"HF Liu","year":"2021","unstructured":"Liu, H. F., Li, Q. & Peng, Y. Q. Alport syndrome combined with lupus nephritis in a Chinese family: A case report. World J. Clin. Cases 9, 4721\u20134727. https:\/\/doi.org\/10.12998\/wjcc.v9.i18.4721 (2021).","journal-title":"World J. Clin. Cases"},{"key":"92520_CR27","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1111\/cge.13182","volume":"93","author":"L He","year":"2018","unstructured":"He, L. et al. Targeted next-generation sequencing and parental genotyping in sporadic Chinese Han deaf patients. Clin. Genet. 93, 899\u2013904. https:\/\/doi.org\/10.1111\/cge.13182 (2018).","journal-title":"Clin. Genet."},{"key":"92520_CR28","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1159\/000368519","volume":"40","author":"C Rosado","year":"2015","unstructured":"Rosado, C., Bueno, E., Felipe, C., Valverde, S. & Gonz\u00e1lez-Sarmiento, R. Study of the true clinical progression of autosomal dominant Alport syndrome in a European population. Kidney Blood Press. Res. 40, 435\u2013442. https:\/\/doi.org\/10.1159\/000368519 (2015).","journal-title":"Kidney Blood Press. Res."},{"key":"92520_CR29","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1007\/s40620-021-01048-4","volume":"34","author":"M Zacchia","year":"2021","unstructured":"Zacchia, M. et al. Nephroplex: a kidney-focused NGS panel highlights the challenges of PKD1 sequencing and identifies a founder BBS4 mutation. J. Nephrol. 34, 1855\u20131874. https:\/\/doi.org\/10.1007\/s40620-021-01048-4 (2021).","journal-title":"J. Nephrol."},{"key":"92520_CR30","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.1053\/j.ajkd.2007.09.028","volume":"51","author":"C Cook","year":"2008","unstructured":"Cook, C., Friedrich, C. A., Baliga, R. & Novel COL4A3 mutations in African American siblings with autosomal recessive Alport syndrome. Am. J. Kidney Dis. 51, e25\u201328. https:\/\/doi.org\/10.1053\/j.ajkd.2007.09.028 (2008).","journal-title":"Am. J. Kidney Dis."},{"key":"92520_CR31","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/humu.9349","volume":"26","author":"M Nagel","year":"2005","unstructured":"Nagel, M., Nagorka, S. & Gross, O. Novel COL4A5, COL4A4, and COL4A3 mutations in Alport syndrome. Hum. Mutat. 26, 60. https:\/\/doi.org\/10.1002\/humu.9349 (2005).","journal-title":"Hum. Mutat."},{"key":"92520_CR32","doi-asserted-by":"publisher","first-page":"838983","DOI":"10.3389\/fmed.2022.838983","volume":"9","author":"H Deng","year":"2022","unstructured":"Deng, H., Zhang, Y., Ding, J. & Wang, F. Presumed COL4A3\/COL4A4 missense\/synonymous variants induce aberrant splicing. Front. Med. (Lausanne) 9, 838983. https:\/\/doi.org\/10.3389\/fmed.2022.838983 (2022).","journal-title":"Front. Med. (Lausanne)"},{"key":"92520_CR33","doi-asserted-by":"publisher","first-page":"933636","DOI":"10.3389\/fgene.2022.933636","volume":"13","author":"M Gao","year":"2022","unstructured":"Gao, M. et al. Diagnostic application of exome sequencing in Chinese children with suspected inherited kidney diseases. Front. Genet. 13, 933636. https:\/\/doi.org\/10.3389\/fgene.2022.933636 (2022).","journal-title":"Front. Genet."},{"key":"92520_CR34","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1007\/s00467-014-2797-4","volume":"29","author":"M Oka","year":"2014","unstructured":"Oka, M. et al. Natural history of genetically proven autosomal recessive Alport syndrome. Pediatr. Nephrol. 29, 1535\u20131544. https:\/\/doi.org\/10.1007\/s00467-014-2797-4 (2014).","journal-title":"Pediatr. Nephrol."},{"key":"92520_CR35","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12882-022-02671-4","volume":"23","author":"A Omori","year":"2022","unstructured":"Omori, A. et al. Disruption of the glomerular basement membrane associated with nutcracker syndrome and double inferior Vena Cava in Noonan syndrome: A case report. BMC Nephrol. 23, 65. https:\/\/doi.org\/10.1186\/s12882-022-02671-4 (2022).","journal-title":"BMC Nephrol."},{"key":"92520_CR36","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1186\/s12882-020-01962-y","volume":"21","author":"L Zhang","year":"2020","unstructured":"Zhang, L., Sun, B. C., Zhao, B. G. & Ma, Q. S. An overview of the multi-pronged approach in the diagnosis of Alport syndrome for 22 children in Northeast China. BMC Nephrol. 21, 294. https:\/\/doi.org\/10.1186\/s12882-020-01962-y (2020).","journal-title":"BMC Nephrol."},{"key":"92520_CR37","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1007\/s00467-015-3302-4","volume":"31","author":"S Weber","year":"2016","unstructured":"Weber, S. et al. Identification of 47 novel mutations in patients with Alport syndrome and thin basement membrane nephropathy. Pediatr. Nephrol. 31, 941\u2013955. https:\/\/doi.org\/10.1007\/s00467-015-3302-4 (2016).","journal-title":"Pediatr. Nephrol."},{"key":"92520_CR38","doi-asserted-by":"publisher","first-page":"402","DOI":"10.23876\/j.krcp.20.111","volume":"39","author":"K Nozu","year":"2020","unstructured":"Nozu, K. et al. Genetic background, recent advances in molecular biology, and development of novel therapy in Alport syndrome. Kidney Res. Clin. Pract. 39, 402\u2013413. https:\/\/doi.org\/10.23876\/j.krcp.20.111 (2020).","journal-title":"Kidney Res. Clin. Pract."},{"key":"92520_CR39","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1007\/s00467-019-04394-5","volume":"35","author":"F Tokhmafshan","year":"2020","unstructured":"Tokhmafshan, F. et al. A no-nonsense approach to hereditary kidney disease. Pediatr. Nephrol. 35, 2031\u20132042. https:\/\/doi.org\/10.1007\/s00467-019-04394-5 (2020).","journal-title":"Pediatr. Nephrol."},{"key":"92520_CR40","doi-asserted-by":"publisher","first-page":"748","DOI":"10.3389\/fgene.2018.00748","volume":"9","author":"F Zhu","year":"2018","unstructured":"Zhu, F., Li, W., Li, Z., Zhu, H. & Xiong, J. Identification of a novel COL4A4 variant in compound-heterozygous state in a patient with Alport syndrome and histological findings similar to focal segmental glomerulosclerosis (FSGS). Front. Genet. 9, 748. https:\/\/doi.org\/10.3389\/fgene.2018.00748 (2018).","journal-title":"Front. Genet."},{"key":"92520_CR41","doi-asserted-by":"publisher","first-page":"1064491","DOI":"10.3389\/fgene.2022.1064491","volume":"13","author":"Y Gao","year":"2022","unstructured":"Gao, Y. et al. Identification of COL4A4 variants in Chinese patients with Familial hematuria. Front. Genet. 13, 1064491. https:\/\/doi.org\/10.3389\/fgene.2022.1064491 (2022).","journal-title":"Front. Genet."},{"key":"92520_CR42","doi-asserted-by":"publisher","first-page":"e0177685","DOI":"10.1371\/journal.pone.0177685","volume":"12","author":"JH Liu","year":"2017","unstructured":"Liu, J. H. et al. Novel mutations in COL4A3, COL4A4, and COL4A5 in Chinese patients with Alport syndrome. PLoS One. 12, e0177685. https:\/\/doi.org\/10.1371\/journal.pone.0177685 (2017).","journal-title":"PLoS One"},{"key":"92520_CR43","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1111\/cge.13077","volume":"92","author":"L Papazachariou","year":"2017","unstructured":"Papazachariou, L. et al. Frequent COL4 mutations in Familial microhematuria accompanied by later-onset Alport nephropathy due to focal segmental glomerulosclerosis. Clin. Genet. 92, 517\u2013527. https:\/\/doi.org\/10.1111\/cge.13077 (2017).","journal-title":"Clin. Genet."},{"key":"92520_CR44","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1038\/sj.ki.5002221","volume":"71","author":"M Slajpah","year":"2007","unstructured":"Slajpah, M. et al. Sixteen novel mutations identified in COL4A3, COL4A4, and COL4A5 genes in Slovenian families with Alport syndrome and benign Familial hematuria. Kidney Int. 71, 1287\u20131295. https:\/\/doi.org\/10.1038\/sj.ki.5002221 (2007).","journal-title":"Kidney Int."},{"key":"92520_CR45","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1093\/ndt\/gfi312","volume":"21","author":"I Longo","year":"2006","unstructured":"Longo, I. et al. Autosomal recessive Alport syndrome: An in-depth clinical and molecular analysis of five families. Nephrol. Dial Transplant. 21, 665\u2013671. https:\/\/doi.org\/10.1093\/ndt\/gfi312 (2006).","journal-title":"Nephrol. Dial Transplant."},{"key":"92520_CR46","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1681\/asn.2012100985","volume":"24","author":"H Storey","year":"2013","unstructured":"Storey, H., Savige, J., Sivakumar, V., Abbs, S. & Flinter, F. A. COL4A3\/COL4A4 mutations and features in individuals with autosomal recessive Alport syndrome. J. Am. Soc. Nephrol. 24, 1945\u20131954. https:\/\/doi.org\/10.1681\/asn.2012100985 (2013).","journal-title":"J. Am. Soc. Nephrol."},{"key":"92520_CR47","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1093\/ckj\/sfz176","volume":"13","author":"A Matthaiou","year":"2020","unstructured":"Matthaiou, A., Poulli, T. & Deltas, C. Prevalence of clinical, pathological and molecular features of glomerular basement membrane nephropathy caused by COL4A3 or COL4A4 mutations: A systematic review. Clin. Kidney J. 13, 1025\u20131036. https:\/\/doi.org\/10.1093\/ckj\/sfz176 (2020).","journal-title":"Clin. Kidney J."},{"key":"92520_CR48","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1093\/jmcb\/mju040","volume":"6","author":"J Xie","year":"2014","unstructured":"Xie, J. et al. COL4A3 mutations cause focal segmental glomerulosclerosis. J. Mol. Cell Biol. 6, 498\u2013505. https:\/\/doi.org\/10.1093\/jmcb\/mju040 (2014).","journal-title":"J. Mol. Cell Biol."},{"key":"92520_CR49","doi-asserted-by":"publisher","first-page":"100","DOI":"10.7326\/m17-1319","volume":"168","author":"S Lata","year":"2018","unstructured":"Lata, S. et al. Whole-Exome sequencing in adults with chronic kidney disease: A pilot study. Ann. Intern. Med. 168, 100\u2013109. https:\/\/doi.org\/10.7326\/m17-1319 (2018).","journal-title":"Ann. Intern. Med."},{"key":"92520_CR50","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.xkme.2021.04.014","volume":"3","author":"EVF Pinto","year":"2021","unstructured":"Pinto, E. V. F. et al. Genomics integration into nephrology practice. Kidney Med. 3, 785\u2013798. https:\/\/doi.org\/10.1016\/j.xkme.2021.04.014 (2021).","journal-title":"Kidney Med."},{"key":"92520_CR51","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1159\/000526971","volume":"147","author":"H Xu","year":"2023","unstructured":"Xu, H. et al. Collagen IV and Podocyte-Related gene variants in patients with concurrent IgA nephropathy and thin basement membrane nephropathy. Nephron 147, 301\u2013310. https:\/\/doi.org\/10.1159\/000526971 (2023).","journal-title":"Nephron"},{"key":"92520_CR52","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/j.ajhg.2022.10.013","volume":"109","author":"V Pejaver","year":"2022","unstructured":"Pejaver, V. et al. Calibration of computational tools for missense variant pathogenicity classification and ClinGen recommendations for PP3\/BP4 criteria. Am. J. Hum. Genet. 109, 2163\u20132177. https:\/\/doi.org\/10.1016\/j.ajhg.2022.10.013 (2022).","journal-title":"Am. J. Hum. Genet."},{"key":"92520_CR53","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet. Med. 17, 405\u2013424. https:\/\/doi.org\/10.1038\/gim.2015.30 (2015).","journal-title":"Genet. Med."},{"key":"92520_CR54","unstructured":"Ellard, S. et al. ACGS Best Practice Guidelines for Variant Classification in Rare DIsease 2020. (2020). www.acgs.uk.com"},{"key":"92520_CR55","doi-asserted-by":"publisher","first-page":"1237912","DOI":"10.3389\/fgene.2023.1237912","volume":"14","author":"W Yang","year":"2023","unstructured":"Yang, W. et al. Fetal hyperechoic kidney cohort study and a meta-analysis. Front. Genet. 14, 1237912. https:\/\/doi.org\/10.3389\/fgene.2023.1237912 (2023).","journal-title":"Front. Genet."},{"key":"92520_CR56","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s00467-022-05627-w","volume":"38","author":"JL Alge","year":"2023","unstructured":"Alge, J. L. et al. Variants in genes coding for collagen type IV \u03b1-chains are frequent causes of persistent, isolated hematuria during childhood. Pediatr. Nephrol. 38, 687\u2013695. https:\/\/doi.org\/10.1007\/s00467-022-05627-w (2023).","journal-title":"Pediatr. Nephrol."},{"key":"92520_CR57","doi-asserted-by":"publisher","unstructured":"Zupan, A., Matja\u0161i\u010d, A., Grubelnik, G., Tasi\u0107, V. & Momirovska, A. Mutations in collagen genes in the context of an isolated population. Genes (Basel) 11 https:\/\/doi.org\/10.3390\/genes11111377 (2020).","DOI":"10.3390\/genes11111377"},{"key":"92520_CR58","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s10157-016-1352-y","volume":"21","author":"K Yokota","year":"2017","unstructured":"Yokota, K. et al. Female X-linked Alport syndrome with somatic mosaicism. Clin. Exp. Nephrol. 21, 877\u2013883. https:\/\/doi.org\/10.1007\/s10157-016-1352-y (2017).","journal-title":"Clin. Exp. Nephrol."},{"key":"92520_CR59","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.ekir.2019.03.005","volume":"4","author":"L Bu","year":"2019","unstructured":"Bu, L. et al. Somatic mosaicism in a male patient with X-linked Alport syndrome. Kidney Int. Rep. 4, 1031\u20131035. https:\/\/doi.org\/10.1016\/j.ekir.2019.03.005 (2019).","journal-title":"Kidney Int. Rep."},{"key":"92520_CR60","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s13730-020-00503-8","volume":"9","author":"Y Aoto","year":"2020","unstructured":"Aoto, Y. et al. A case with somatic and germline mosaicism in COL4A5 detected by multiplex ligation-dependent probe amplification in X-linked Alport syndrome. CEN Case Rep. 9, 431\u2013436. https:\/\/doi.org\/10.1007\/s13730-020-00503-8 (2020).","journal-title":"CEN Case Rep."},{"key":"92520_CR61","doi-asserted-by":"crossref","unstructured":"Swee-Hock, S. The Population of Singapore (Third Edition) (Institute of Southeast Asian Studies, 2012).","DOI":"10.1355\/9789814380324"},{"key":"92520_CR62","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1093\/ndt\/gfq084","volume":"25","author":"C Sabanayagam","year":"2010","unstructured":"Sabanayagam, C. et al. Ethnic disparities in prevalence and impact of risk factors of chronic kidney disease. Nephrol. Dialysis Transplant.25, 2564\u20132570. https:\/\/doi.org\/10.1093\/ndt\/gfq084 (2010).","journal-title":"Nephrol. Dialysis Transplant."},{"key":"92520_CR63","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1038\/s41431-021-00858-1","volume":"29","author":"J Savige","year":"2021","unstructured":"Savige, J. et al. Consensus statement on standards and guidelines for the molecular diagnostics of Alport syndrome: Refining the ACMG criteria. Eur. J. Hum. Genet. 29, 1186\u20131197. https:\/\/doi.org\/10.1038\/s41431-021-00858-1 (2021).","journal-title":"Eur. J. Hum. Genet."},{"key":"92520_CR64","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1002\/humu.24088","volume":"41","author":"SV Tavtigian","year":"2020","unstructured":"Tavtigian, S. V., Harrison, S. M., Boucher, K. M. & Biesecker, L. G. Fitting a naturally scaled point system to the ACMG\/AMP variant classification guidelines. Hum. Mutat. 41, 1734\u20131737. https:\/\/doi.org\/10.1002\/humu.24088 (2020).","journal-title":"Hum. Mutat."},{"key":"92520_CR65","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1038\/gim.2017.210","volume":"20","author":"SV Tavtigian","year":"2018","unstructured":"Tavtigian, S. V. et al. Modeling the ACMG\/AMP variant classification guidelines as a Bayesian classification framework. Genet. Med. 20, 1054\u20131060. https:\/\/doi.org\/10.1038\/gim.2017.210 (2018).","journal-title":"Genet. Med."},{"key":"92520_CR66","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/s41588-022-01274-x","volume":"55","author":"E Wong","year":"2023","unstructured":"Wong, E. et al. The Singapore national precision medicine strategy. Nat. Genet. 55, 178\u2013186. https:\/\/doi.org\/10.1038\/s41588-022-01274-x (2023).","journal-title":"Nat. Genet."},{"key":"92520_CR67","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1046\/j.1523-1755.2001.0590051670.x","volume":"59","author":"M Buzza","year":"2001","unstructured":"Buzza, M., Wilson, D. & Savige, J. Segregation of hematuria in thin basement membrane disease with haplotypes at the loci for Alport syndrome. Kidney Int. 59, 1670\u20131676. https:\/\/doi.org\/10.1046\/j.1523-1755.2001.0590051670.x (2001).","journal-title":"Kidney Int."},{"key":"92520_CR68","doi-asserted-by":"publisher","DOI":"10.2215\/cjn.0000000000000564","author":"C Schott","year":"2024","unstructured":"Schott, C. et al. Utility of genetic testing in adults with chronic kidney disease: A systematic review and meta-analysis. Clin. J. Am. Soc. Nephrol. https:\/\/doi.org\/10.2215\/cjn.0000000000000564 (2024).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"92520_CR69","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1056\/NEJMoa1806891","volume":"380","author":"EE Groopman","year":"2019","unstructured":"Groopman, E. E. et al. Diagnostic utility of exome sequencing for kidney disease. N Engl. J. Med. 380, 142\u2013151. https:\/\/doi.org\/10.1056\/NEJMoa1806891 (2019).","journal-title":"N Engl. J. Med."},{"key":"92520_CR70","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1097\/mnh.0000000000000983","volume":"33","author":"P Puapatanakul","year":"2024","unstructured":"Puapatanakul, P. & Miner, J. H. Alport syndrome and Alport kidney diseases - elucidating the disease spectrum. Curr. Opin. Nephrol. Hypertens. 33, 283\u2013290. https:\/\/doi.org\/10.1097\/mnh.0000000000000983 (2024).","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"92520_CR71","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1093\/ndt\/gfad105","volume":"38","author":"M Zeng","year":"2023","unstructured":"Zeng, M., Di, H., Liang, J. & Liu, Z. Effectiveness of renin-angiotensin-aldosterone system blockers in patients with Alport syndrome: A systematic review and meta-analysis. Nephrol. Dial Transplant. 38, 2485\u20132493. https:\/\/doi.org\/10.1093\/ndt\/gfad105 (2023).","journal-title":"Nephrol. Dial Transplant."},{"key":"92520_CR72","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s00467-020-04819-6","volume":"36","author":"CE Kashtan","year":"2021","unstructured":"Kashtan, C. E. & Gross, O. Clinical practice recommendations for the diagnosis and management of Alport syndrome in children, adolescents, and young adults-an update for 2020. Pediatr. Nephrol. 36, 711\u2013719. https:\/\/doi.org\/10.1007\/s00467-020-04819-6 (2021).","journal-title":"Pediatr. Nephrol."},{"key":"92520_CR73","doi-asserted-by":"publisher","first-page":"100942","DOI":"10.1016\/j.gim.2023.100942","volume":"25","author":"Y Wu","year":"2023","unstructured":"Wu, Y. et al. Genomic testing for suspected Monogenic kidney disease in children and adults: A health economic evaluation. Genet. Med. 25, 100942. https:\/\/doi.org\/10.1016\/j.gim.2023.100942 (2023).","journal-title":"Genet. Med."},{"key":"92520_CR74","unstructured":"United States Renal Data System. USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States (National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2023)."},{"key":"92520_CR75","doi-asserted-by":"publisher","unstructured":"Lim, C. et al. Clinical implementation of Nephrologist-led genomic testing for glomerular diseases in Singapore: Rationale and protocol. Am. J. Nephrol. 1\u201320. https:\/\/doi.org\/10.1159\/000542942 (2024).","DOI":"10.1159\/000542942"},{"key":"92520_CR76","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.kint.2023.05.006","volume":"104","author":"M Boisson","year":"2023","unstructured":"Boisson, M. et al. A wave of deep intronic mutations in X-linked Alport syndrome. Kidney Int. 104, 367\u2013377. https:\/\/doi.org\/10.1016\/j.kint.2023.05.006 (2023).","journal-title":"Kidney Int."},{"key":"92520_CR77","unstructured":"Geraldine, A. & Van der Auwera, B. D. O. C. Genomics in the Cloud: Using Docker, GATK, and WDL in Terra (1st Edition). (O\u2019Reilly Media, Inc., (2020)."},{"key":"92520_CR78","doi-asserted-by":"publisher","unstructured":"Ryan, P. et al. Scaling accurate genetic variant discovery to tens of thousands of samples. BioRxiv 201178 https:\/\/doi.org\/10.1101\/201178 (2018).","DOI":"10.1101\/201178"},{"key":"92520_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40246-014-0023-x","volume":"9","author":"TB Mersha","year":"2015","unstructured":"Mersha, T. B. & Abebe, T. Self-reported race\/ethnicity in the age of genomic research: its potential impact on Understanding health disparities. Hum. Genomics. 9, 1. https:\/\/doi.org\/10.1186\/s40246-014-0023-x (2015).","journal-title":"Hum. Genomics"},{"key":"92520_CR80","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1093\/bioinformatics\/bty897","volume":"35","author":"C Kopanos","year":"2019","unstructured":"Kopanos, C. et al. VarSome: the human genomic variant search engine. Bioinformatics 35, 1978\u20131980. https:\/\/doi.org\/10.1093\/bioinformatics\/bty897 (2019).","journal-title":"Bioinformatics"},{"key":"92520_CR81","unstructured":"Group, C. S. V. I. S. W. ClinGen Sequence Variant Interpretation Recommendation for PM2 - Version 1.0, (2020). https:\/\/clinicalgenome.org\/site\/assets\/files\/5182\/pm2_-_svi_recommendation_-_approved_sept2020.pdf"},{"key":"92520_CR82","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1038\/gim.2018.42","volume":"20","author":"LG Biesecker","year":"2018","unstructured":"Biesecker, L. G. & Harrison, S. M. ClinGen sequence variant interpretation working, G. The ACMG\/AMP reputable source criteria for the interpretation of sequence variants. Genet. Med. 20, 1687\u20131688. https:\/\/doi.org\/10.1038\/gim.2018.42 (2018).","journal-title":"Genet. Med."},{"key":"92520_CR83","doi-asserted-by":"publisher","first-page":"577152","DOI":"10.3389\/fgene.2020.577152","volume":"11","author":"LM Chunn","year":"2020","unstructured":"Chunn, L. M. et al. Mastermind: A comprehensive genomic association search engine for empirical evidence curation and genetic variant interpretation. Front. Genet. 11, 577152. https:\/\/doi.org\/10.3389\/fgene.2020.577152 (2020).","journal-title":"Front. Genet."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92520-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92520-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92520-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T02:15:37Z","timestamp":1741140937000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92520-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,5]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["92520"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-92520-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,5]]},"assertion":[{"value":"28 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7691"}}